"In vitro" inhibition of platelet aggregation by uremic middle molecules.
"Uremic middle molecules" are isolated from the urine of normal subjects and the blood in chronic renal insufficiency treated by hemodialysis. Their action is tested in vitro on platelets aggregation induced by ADP. Some fractions of these middle molecules (fractions 7b, 7c and 7 "fg") are without any effect. The 7 "de" fractions give an inhibition of platelets aggregation. The percentage variations of first phase inhibition as a function of the middle molecules concentrations is studied.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D008970:Molecular Weight; D010974:Platelet Aggregation; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood*
D000244:Adenosine Diphosphate